Esnani, Saina .

HRN: 07-20-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2026
CEFUROXIME 500MG (TAB)
06/04/2026
06/11/2026
PO
500
Bid
Mastitis
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: